CN101849985B - Chinese medicament for treating tachycardia - Google Patents
Chinese medicament for treating tachycardia Download PDFInfo
- Publication number
- CN101849985B CN101849985B CN2009102358782A CN200910235878A CN101849985B CN 101849985 B CN101849985 B CN 101849985B CN 2009102358782 A CN2009102358782 A CN 2009102358782A CN 200910235878 A CN200910235878 A CN 200910235878A CN 101849985 B CN101849985 B CN 101849985B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- chinese medicament
- tachycardia
- chuanxiong
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
技术领域technical field
本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.
背景技术Background technique
目前旨在治疗心动过速的中药领域,存在一些不足:一是效果不够明显,二是见效比较迟缓。以致于许多心动过速的中老年人长期受心慌、心悸、胸闷、心跳过快的折磨,严重影响了生活质量,患者及其家属对此不够满意。At present, there are some shortcomings in the field of traditional Chinese medicine aimed at treating tachycardia: the first is that the effect is not obvious enough, and the second is that the effect is relatively slow. As a result, many middle-aged and elderly people with tachycardia suffer from palpitation, heart palpitations, chest tightness, and rapid heartbeat for a long time, which seriously affects the quality of life, and patients and their families are not satisfied with this.
针对以上提出的问题,本发明提供一种治疗心动过速的中药,它能解决以往此类中药效果不够明显,见效比较迟缓的问题,效果好、见效快,具有效果显著,药效确切,见效较快的优点。In view of the problems raised above, the present invention provides a traditional Chinese medicine for the treatment of tachycardia, which can solve the problem that the effect of such traditional Chinese medicines is not obvious enough in the past, and the effect is relatively slow. The advantage of being faster.
发明内容Contents of the invention
本发明是通过以下技术方案来实现的:The present invention is achieved through the following technical solutions:
1、一种治疗心动过速的中药,采用中药原料制备,配方为(按重量比):1, a kind of Chinese medicine for the treatment of tachycardia, adopts Chinese medicine raw material to prepare, and formula is (by weight):
降香3-20份 灵芝2-12份 三七3-20份3-20 parts of Jiangxiang, 2-12 parts of Ganoderma lucidum, 3-20 parts of Panax notoginseng
川芎4-30份Chuanxiong 4-30 parts
这种治疗心动过速的中药是由下列方法制成的:This traditional Chinese medicine for treating tachycardia is made by the following method:
(1)按上述重量比,将降香、川芎经常规水提取工艺提取,制成浸膏细粉;(1) according to the above-mentioned weight ratio, jiangxiang and chuanxiong are extracted through a conventional water extraction process to make extract powder;
(2)按上述重量比,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀;根据需要,可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.
本发明是根据民间传统配方,根据中医扶正培本、活血化瘀的理论,精心研制而成。方中灵芝益气养血,养心安神,扶正培本,增强机体免疫力;川芎、三七养血活血,化瘀止痛;降香温通行滞,化瘀通络安脉。诸药配伍,相得益彰,共奏扶正培本,益气养血,活血化瘀通脉之功,效果好,见效快,具有效果显著,药效确切,见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum nourishes qi and blood, nourishes the heart and calms the nerves, strengthens the body and strengthens the body's immunity; Chuanxiong and Panax notoginseng nourish and activate blood, remove blood stasis and relieve pain; All the medicines are compatible and complement each other, and they play the functions of strengthening the body, nourishing qi and nourishing the blood, promoting blood circulation, removing blood stasis and dredging the meridians. The effect is good, and the effect is fast.
具体实施方式Detailed ways
通过以下实施方式对本发明做具体说明:The present invention is specifically described by the following embodiments:
1、取以下配方(重量按克为单位):1. Take the following formula (weight is in grams):
降香60克 灵芝40克 三七60克Dalbergia 60g Ganoderma lucidum 40g Panax notoginseng 60g
川芎80克Chuanxiong 80g
按规定重量,用常规水提取工艺将降香、川芎提取,制成浸膏细粉42克,将灵芝、三七分别研成细粉,与上述浸膏细粉混合,搅拌均匀,制成细小颗粒,装入0号胶囊,制成中药胶囊507粒,每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, use the conventional water extraction process to extract Jiangxiang and Chuanxiong to make 42 grams of extract powder. Grind Ganoderma lucidum and Panax notoginseng into fine powder, mix with the above extract powder, stir evenly, and make fine powder. Granules, packed into No. 0 capsules, made into 507 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.
2、取以下配方(重量按克为单位):2. Take the following formula (weight is in grams):
降香100克 灵芝60克 三七100克Dalbergia 100g Ganoderma lucidum 60g Panax notoginseng 100g
川芎160克Chuanxiong 160g
按上述同样的方法,制成中药胶囊850粒,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, make 850 Chinese medicine capsules, each capsule contains Chinese medicine fine powder and extract 0.28 gram.
3、取以下配方(重量按克为单位):3. Take the following formula (the weight is in grams):
降香200克 灵芝120克 三七200克Dalbergia 200g Ganoderma lucidum 120g Panax notoginseng 200g
川芎300克Chuanxiong 300g
按上述同样的方法,制成中药胶囊1678粒,每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1678 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
4、取以下配方(按重量比):4. Take the following formula (by weight):
降香6份 灵芝4份 三七6份6 parts of Jiangxiang 4 parts of Ganoderma lucidum 6 parts of Panax notoginseng
川芎8份Chuanxiong 8 parts
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
5、取以下配方(按重量比):5. Take the following formula (by weight):
降香15份 灵芝8份 三七15份15 parts of Jiangxiang, 8 parts of Ganoderma lucidum, 15 parts of Panax notoginseng
川芎25份Chuanxiong 25 parts
按上述同样的方法,制成中药胶囊,每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
临床资料:clinical information:
本发明以中医心动过速为例,经8例临床观察。选择中医诊断心悸、心动过速为标准:发作时脉搏过快,心慌心乱,胸部胀闷,四肢发麻,肢软乏力,心率160次/分钟左右。如上症状,即可确诊。在确诊观察的对象中,男性5例,女性3例,无其它严重疾病,年龄为41岁-80岁,平均年龄64.2岁。The present invention takes TCM tachycardia as an example, through 8 clinical observations. TCM diagnosis of palpitations and tachycardia was selected as the standard: the pulse was too fast during the attack, palpitation and confusion, chest distension, numbness of the limbs, weakness and weakness of the limbs, and the heart rate was about 160 beats/min. The above symptoms can be diagnosed. Among the confirmed observation objects, there were 5 males and 3 females, without other serious diseases, aged from 41 to 80 years old, with an average age of 64.2 years.
疗效判定:Judgment of curative effect:
1、显效:体质增强,四肢有劲,心慌心悸等心区不适明显缓解或消失,心区舒适,心率100次/分钟以下。1. Significant effect: Physical fitness is enhanced, limbs are strong, palpitations and palpitations and other heart discomfort are obviously relieved or disappeared, the heart area is comfortable, and the heart rate is below 100 beats/min.
2、有效:体质增强,心慌心悸等心区不适有所缓解。2. Effective: physical fitness is strengthened, palpitation and heart palpitations are alleviated.
3、无效:病症无变化。3. Ineffective: no change in symptoms.
临床实验时,停服其它药物和保健营养品。服用本发明中药胶囊,观察3个月,为一个疗程。服用方法:每日2次,每次4粒胶囊,每粒胶囊内含中药细粉及提取物0.28克,饭后温开水送服,30天后症状即有缓解,服用3个月后,症状明显改善。临床实验的8人中,显效4人,有效3人,无效1人,总有效率87.5%。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 2 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 8 people in the clinical trial, 4 people were markedly effective, 3 people were effective, and 1 person was ineffective, and the total effective rate was 87.5%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358782A CN101849985B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating tachycardia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102358782A CN101849985B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating tachycardia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101849985A CN101849985A (en) | 2010-10-06 |
| CN101849985B true CN101849985B (en) | 2011-06-29 |
Family
ID=42801774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102358782A Expired - Fee Related CN101849985B (en) | 2009-10-28 | 2009-10-28 | Chinese medicament for treating tachycardia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101849985B (en) |
-
2009
- 2009-10-28 CN CN2009102358782A patent/CN101849985B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101849985A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843787A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843661B (en) | Chinese medicament for treating angina | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101537121B (en) | Chinese medicine for treating arteriosclerosis | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101850015B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843645B (en) | Chinese medicament for treating tachycardia | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101396468B (en) | A kind of traditional Chinese medicine for treating diabetic coronary heart disease | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101850018A (en) | Chinese medicine for treating cervical spondylosis | |
| CN101843786A (en) | Chinese medicament for treating diabetic eyeground pathological changes | |
| CN101843720B (en) | Chinese medicament for treating angina | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843672B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843831B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101850054B (en) | Chinese medicament for treating diabetic heart diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843796A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843646A (en) | Chinese medicament for treating tachycardia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130701 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130701 Address after: 226500 Rugao province Jiangsu City Jiangan Town Road No. 166. Patentee after: RUGAO BINJIANG URBAN CONSTRUCTION INVESTMENT CO., LTD. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20151028 |
|
| EXPY | Termination of patent right or utility model |